Galephar Pharmaceutical Research INC
At a glance
Employees100-499
In business sinceNot reported
HeadquartersHumacao, PR
US patents6
SAM.gov UEIT1WTEN8UEF47
CAGE code9M9X9
Incorporated inPR
Supplier designations
For Profit OrganizationManufacturer of GoodsMinority Owned Business
Self-certified by the company in its SAM.gov registration
Patents
6 US patents granted 2010–2020, none of them in the five years to SEP 2025.
Pharmaceuticals 6
- Pharmaceutical anti-infective composition for inhalationUS 10,709,723 · granted JUL 14, 2020
- Pharmaceutical semi-solid composition of isotretinoinUS 9,089,534 · granted JUL 28, 2015
- Pharmaceutical semi-solid composition of isotretinoinUS 9,078,925 · granted JUL 14, 2015
- Pharmaceutical semi-solid composition of isotretinoinUS 8,952,064 · granted FEB 10, 2015
- Pharmaceutical semi-solid composition of isotretinoinUS 8,367,102 · granted FEB 5, 2013
Newest 5 shown · Granted to Galephar Pharmaceutical Research, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Galephar Pharmaceutical Research INC | Humacao | PR | 100–499 | ACTIVE |
| Galephar Pharmaceutical Research INC | Juncos | PR | — | UNVERIFIED |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.